These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 103147

  • 1. [Bence-Jones myeloma. Clinical aspects, analysis and evolution].
    Sanchez de cos Escuin J, Moreno Norueira J, Carneado de la Fuente J.
    Rev Clin Esp; 1978 Sep 30; 150(6):345-9. PubMed ID: 103147
    [No Abstract] [Full Text] [Related]

  • 2. Double Bence Jones proteinuria.
    Kanoh T, Yago K.
    Arch Pathol Lab Med; 1990 Sep 30; 114(9):991-4. PubMed ID: 2117911
    [Abstract] [Full Text] [Related]

  • 3. Histology and function of the kidney in marked Bence Jones paraproteinuria.
    Nagengast FM, Assmann KJ, Fennis JF.
    Neth J Med; 1980 Sep 30; 23(1):38. PubMed ID: 6767990
    [No Abstract] [Full Text] [Related]

  • 4. Free light chains of immunoglobulins.
    Solling K.
    Scand J Clin Lab Invest Suppl; 1981 Sep 30; 157():1-83. PubMed ID: 6797039
    [No Abstract] [Full Text] [Related]

  • 5. [Lung cancer associated with two M-proteins (IgA-kappa, IgA-lambda) in serum and bence jones protein (lambda-type) in urine; report of a case].
    Imai H, Nakamoto Y, Akihama T, Kuwayama A, Miura A, Sato T, Uesaka Y, Watanuki T.
    Rinsho Ketsueki; 1982 Oct 30; 23(10):1578-83. PubMed ID: 6818391
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
    Abraham RS, Clark RJ, Bryant SC, Lymp JF, Larson T, Kyle RA, Katzmann JA.
    Clin Chem; 2002 Oct 30; 48(4):655-7. PubMed ID: 11901068
    [No Abstract] [Full Text] [Related]

  • 7. [IgM myeloma].
    Assaf ME, Pizzolato MA, De María HE, Gasparini S, Burucua JE.
    Sangre (Barc); 1983 Oct 30; 28(5):642-7. PubMed ID: 6420914
    [No Abstract] [Full Text] [Related]

  • 8. Measuring Bence Jones proteins with antibodies against bound immunoglobulin light-chains: how reliable are the results?
    Boege F.
    Eur J Clin Chem Clin Biochem; 1993 Jun 30; 31(6):403-5. PubMed ID: 8369369
    [Abstract] [Full Text] [Related]

  • 9. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
    Iavorskiĭ LI, Andreeva NE, Antipova LG, Riauzova LN.
    Probl Gematol Pereliv Krovi; 1979 Jun 30; 24(6):3-9. PubMed ID: 111238
    [No Abstract] [Full Text] [Related]

  • 10. Novel immunization protocol and ELISA screening methods used to obtain and characterize monoclonal antibodies specific for human light chain variable-region subgroups.
    Abe M, Goto T, Wolfenbarger D, Weiss DT, Solomon A.
    Hybridoma; 1993 Aug 30; 12(4):475-83. PubMed ID: 8244419
    [Abstract] [Full Text] [Related]

  • 11. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
    Fujii H, Kanoh T.
    Nihon Naika Gakkai Zasshi; 1981 Nov 10; 70(11):1553-61. PubMed ID: 6801164
    [No Abstract] [Full Text] [Related]

  • 12. [A case report of multiple myeloma with marked Bence Jones proteinuria but slight serum mono component (IgG-kappa), showing lymphoid plasma cells in the bone marrow].
    Hishitani Y, Shinoda K, Yasui T, Mozai T, Kanoh T, Yasuda N.
    Rinsho Ketsueki; 1984 Nov 10; 25(11):1831-6. PubMed ID: 6442739
    [No Abstract] [Full Text] [Related]

  • 13. [Analysis of amyloidosis in myeloma. Clinical, biological and prognostic study].
    Zamora P, Fernández Martín J, Barbado FJ, Vicandi B, Encinas A, Gil A, Arnalich F, Vázquez JJ.
    Rev Clin Esp; 1986 May 10; 178(9):428-31. PubMed ID: 3090651
    [No Abstract] [Full Text] [Related]

  • 14. [IgG-lambda myeloma protein "nonreactive" with anti-IgG-Fab and anti-light chain antisera].
    Niiya K, Taguchi H, Yoshimoto S, Miyoshi I, Fujishita M, Yube T.
    Rinsho Ketsueki; 1983 May 10; 24(5):588-93. PubMed ID: 6411950
    [No Abstract] [Full Text] [Related]

  • 15. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
    Diop PA, Haudrechy D, Sylla-Niang M, Diedhiou A, Ngom L, Lopez-Sall P.
    Bull Soc Pathol Exot; 1998 May 10; 91(3):242-6. PubMed ID: 9773201
    [Abstract] [Full Text] [Related]

  • 16. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ, McKenna PJ, Halperin I, Chung FJ.
    Ann Clin Lab Sci; 1978 May 10; 8(3):209-18. PubMed ID: 418730
    [Abstract] [Full Text] [Related]

  • 17. [Myeloma with intermittent secretion. Presentation of a case].
    Pascua Molina J, Sánchez de Cos Escuín J, Agustín Herrero J, Serviá García F, Santos Mayordomo A, Enríquez Acosta L.
    Rev Clin Esp; 1978 May 10; 165(5-6):371-4. PubMed ID: 6813922
    [No Abstract] [Full Text] [Related]

  • 18. Serologically defined V region subgroups of human lambda light chains.
    Solomon A, Weiss DT.
    J Immunol; 1987 Aug 01; 139(3):824-30. PubMed ID: 3110284
    [Abstract] [Full Text] [Related]

  • 19. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma.
    Hom BL.
    Am J Clin Pathol; 1984 Nov 01; 82(5):627-9. PubMed ID: 6437210
    [Abstract] [Full Text] [Related]

  • 20. Tubular proteinuria in myeloma.
    Ballocchi S, Bergonzi G, Dall'Aglio P, Fontana F, Gandi U, Pantano E, Poisetti P, Scarpioni L.
    Ric Clin Lab; 1980 Nov 01; 10(1):149-56. PubMed ID: 6781042
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.